enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pfizer makes equity investment in Caribou Biosciences - AOL

   www.aol.com/news/pfizer-makes-equity-investment...

   The news lifted shares of Caribou more than 61% in early trade. Pfizer purchased nearly 4.7 million Caribou shares at $5.33 per share, Caribou said on Thursday, representing a premium of about 30% ...

3. Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags ... - AOL

   www.aol.com/news/caribou-biosciences-inc-crbu...

   Caribou Biosciences, Inc. (CRBU) delivered earnings and revenue surprises of 8.33% and 8.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for ...

4. Growth Investors: Industry Analysts Just Upgraded Their ... - AOL

   www.aol.com/news/growth-investors-industry...

   Caribou Biosciences, Inc. ( NASDAQ:CRBU ) shareholders will have a reason to smile today, with the analysts making... Growth Investors: Industry Analysts Just Upgraded Their Caribou Biosciences ...

5. Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

   lite.aol.com/tech/story/0022/20250102/9325386.htm

   BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Sri Ryali as chief financial officer, effective immediately. Mr.

6. Caribou Biosciences to Participate in Upcoming Investor ...

   lite.aol.com/tech/story/0022/20241120/9277336.htm

   Caribou is deploying the power of its chRDNA technology to carry out high efficiency multiple edits, to develop CRISPR-edited therapies. About Caribou Biosciences, Inc. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases ...

7. Intellia Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Intellia_Therapeutics

   Intellia Therapeutics was founded in November 2014 to develop biopharmaceuticals using CRISPR. [7] [8]It was backed by Atlas Venture and Novartis; the founding CEO was Nessan Bermingham from Atlas and the founding CSO was John Leonard, formerly CSO of AbbVie.

8. Rachel Haurwitz - Wikipedia

   en.wikipedia.org/wiki/Rachel_Haurwitz

   In 2011, Haurwitz and Doudna co-founded Caribou Biosciences, a gene editing spinout-startup company. [7] Haurwitz is the company's CEO and president. She holds several patents for CRISPR-based technologies. [5] The firm was initially housed in the basement of the building that housed Doudna's laboratory.

9. Here's What Analysts Are Forecasting For Caribou Biosciences ...

   www.aol.com/news/heres-analysts-forecasting...

   One of the biggest stories of last week was how Caribou Biosciences, Inc. ( NASDAQ:CRBU ) shares plunged 21% in the...